The demand for eyedrop manufacturing in India is increasing steadily in 2026 because eye-related problems are becoming more common due to lifestyle changes, long screen exposure, pollution, and aging-related conditions. 

Recent studies show that around 37% of people in urban India suffer from dry eye disease, and prolonged screen time above 4 hours per day significantly increases the risk of dry eye symptoms. In urban clinics, doctors also report a continuous rise in cases, with 15–20 patients every week showing dry eye symptoms, especially among working professionals and students. As more people face issues like dry eyes, infections, and glaucoma, the need for safe and sterile eye drop products is also rising. 

This growing health need is directly pushing pharmaceutical brands to depend more on reliable eye drop manufacturers in India. 

Key Factors Behind This Growth

India’s eyedrop market is valued at around USD 219.9 million in 2025 and is expected to reach about USD 316 million by 2034. This shows that the market is growing at nearly 4% every year. In simple terms, the eye drop industry in India is not growing suddenly, but it is increasing steadily year after year, which clearly shows a stable and long-term rise in demand.

This growth is also supported by the increasing demand for ophthalmic medicines in both domestic and export markets. Pharma companies are focusing more on specialized and sterile products, and eye drops fall into a highly sensitive category where quality and safety standards are extremely important. Because of this, manufacturing demand is rising in a structured way rather than random expansion.

How Eye Drop Manufacturing Companies Are Scaling in India

Eyedrop manufacturing requires a highly controlled sterile environment because even a small contamination can affect product safety. That is why modern eyedrop manufacturing companies in India are upgrading their facilities with advanced cleanroom systems, automated filling machines, and strict quality control processes.

Many manufacturing units are now designed to handle large-scale production while still maintaining WHO-GMP and other regulatory standards. This shift shows that eyedrop manufacturing in India is no longer a small-scale operation but a highly organized and technology-driven industry that is capable of meeting both domestic and global demand.

Why Pharma Brands Are Choosing Contract Eye Drop Manufacturers

Most pharma brands in India prefer contract eye drop manufacturing because setting up a sterile production facility requires very high investment, strict approvals, and continuous compliance management. Instead of handling all of this internally, brands find it easier and faster to work with established manufacturers.

This approach helps companies reduce production costs, speed up product launch, and focus more on branding and distribution rather than manufacturing complexity. As a result, contract manufacturing has become a major driver of growth in the eye drop industry in India.

Conclusion: Strong Growth Outlook for 2026 and Beyond

The eye drop manufacturing sector in India is showing steady and long-term growth as demand for ophthalmic care continues to rise. With increasing market size, stronger regulatory standards, and growing dependence on contract manufacturing, India is becoming an important hub for eye drop production.

For pharmaceutical brands, this creates a clear opportunity to work with reliable manufacturing partners and scale their presence in both domestic and international markets.